Back to Search
Start Over
Osteoblast derived-neurotrophin‑3 induces cartilage removal proteases and osteoclast-mediated function at injured growth plate in rats.
- Source :
-
Bone [Bone] 2018 Nov; Vol. 116, pp. 232-247. Date of Electronic Publication: 2018 Aug 17. - Publication Year :
- 2018
-
Abstract
- Faulty bony repair causes dysrepair of injured growth plate cartilage and bone growth defects in children; however, the underlying mechanisms are unclear. Recently, we observed the prominent induction of neurotrophin‑3 (NT-3) and its important roles as an osteogenic and angiogenic factor promoting the bony repair. The current study investigated its roles in regulating injury site remodelling. In a rat tibial growth plate drill-hole injury repair model, NT-3 was expressed prominently in osteoblasts at the injury site. Recombinant NT-3 (rhNT-3) systemic treatment enhanced, but NT-3 immunoneutralization attenuated, expression of cartilage-removal proteases (MMP-9 and MMP-13), presence of bone-resorbing osteoclasts and expression of osteoclast protease cathepsin K, and remodelling at the injury site. NT-3 was also highly induced in cultured mineralizing rat bone marrow stromal cells, and the conditioned medium augmented osteoclast formation and resorptive activity, an ability that was blocked by presence of anti-NT-3 antibody. Moreover, NT-3 and receptor TrkC were induced during osteoclastogenesis, and rhNT-3 treatment activated TrkC downstream kinase Erk1/2 in differentiating osteoclasts although rhNT-3 alone did not affect activation of osteoclastogenic transcription factors NF-κB or NFAT in RAW <subscript>264.7</subscript> osteoclast precursor cells. Furthermore, rhNT-3 treatment increased, but NT-3 neutralization reduced, expression of osteoclastogenic cytokines (RANKL, TNF-α, and IL-1) in mineralizing osteoblasts and in growth plate injury site, and rhNT-3 augmented the induction of these cytokines caused by RANKL treatment in RAW <subscript>264.7</subscript> cells. Thus, injury site osteoblast-derived NT-3 is important in promoting growth plate injury site remodelling, as it induces cartilage proteases for cartilage removal and augments osteoclastogenesis and resorption both directly (involving activing Erk1/2 and substantiating RANKL-induced increased expression of osteoclastogenic signals in differentiating osteoclasts) and indirectly (inducing osteoclastogenic signals in osteoblasts).<br /> (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Bony Callus metabolism
Bony Callus pathology
Cytokines metabolism
Enzyme Activation drug effects
Growth Plate drug effects
Humans
Male
Mice
NF-kappa B metabolism
NFATC Transcription Factors metabolism
Osteoblasts drug effects
Osteoblasts pathology
Osteoclasts drug effects
Osteogenesis drug effects
RANK Ligand pharmacology
RAW 264.7 Cells
RNA, Messenger genetics
RNA, Messenger metabolism
Rats, Sprague-Dawley
Receptor, trkC metabolism
Cartilage, Articular pathology
Growth Plate metabolism
Growth Plate pathology
Neurotrophin 3 metabolism
Osteoblasts metabolism
Osteoclasts metabolism
Peptide Hydrolases metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1873-2763
- Volume :
- 116
- Database :
- MEDLINE
- Journal :
- Bone
- Publication Type :
- Academic Journal
- Accession number :
- 30125729
- Full Text :
- https://doi.org/10.1016/j.bone.2018.08.010